Filter by: patients
Home > Community Treatment Reports and Side Effects > Dorsal Spinal Cord Stimulator Treatment Report
What is Dorsal Spinal Cord Stimulator?

Dorsal Column Stimulator (DCS) is an implantable medical device used to treat chronic pain of neurologic origin. An electric impulse generated by the device near the dorsal surface of the spinal cord provides a paresthesia ("tingling") sensation that alters the perception of pain by the patient.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
chronic lower back/abdominal pain 1 1 Efficacy_none
Pain in lower back 1 0
Peripheral Neuropathy 1 0

See all 4 patients currently using Dorsal Spinal Cord Stimulator

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 1
Moderate
 0
Mild
 0
None
 0

Commonly reported side effects, conditions, and hospitalizations associated with Dorsal Spinal Cord Stimulator

Hospitalization 2
placement issues 1

Reported Stop Reasons

Why Patients Stopped Using (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 1   Side effects too severe: 50%
Other 1   Other: 50%

See all 2 patients who’ve stopped using Dorsal Spinal Cord Stimulator

Reported Duration See details about how long patients take this treatment ▼

How Long Current Patients Have Been Using Dorsal Spinal Cord Stimulator

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Dorsal Spinal Cord Stimulator

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Dorsal Spinal Cord Stimulator

Very
 1 100%
Somewhat
 0 0%
A little
 0 0%
Not at all
 0 0%

Cost

Paid out of pocket

Cost of Dorsal Spinal Cord Stimulator

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

Report created on February 12, 2012.